Stay updated on Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.

Latest updates to the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedAdded a Locations section with Anhui, Guangdong, Heilongjiang, Jiangsu, and Zhejiang, and removed the individual location subsections. This update is reflected in Revision: v3.3.3.SummaryDifference0.7%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe study status was updated to Completed and the page now includes complete details for the Fruquintinib+paclitaxel and Fruquintinib placebo+paclitaxel arms, including start, completion dates, and related treatment descriptions.SummaryDifference1%

- Check32 days agoChange DetectedThe PubMed publications notice on the study page was updated to indicate automatic filling from PubMed, and the Revision version changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedThe funding status and operating updates notice has been removed from the page, so it now presents only the study details.SummaryDifference0.4%

- Check60 days agoChange DetectedNo significant changes to the study details, eligibility criteria, outcomes, or locations; only minor formatting and layout adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check82 days agoChange DetectedKey changes: published a government-funding status notice affecting operations and a new version v3.2.0; the previous v3.1.0 deletion indicates an update rather than a removal of functionality.SummaryDifference3%

Stay in the know with updates to Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Frquintinib + Paclitaxel in Gastric Cancer Clinical Trial page.